URGN•benzinga•
Scotiabank Initiates Coverage On UroGen Pharma with Sector Outperform Rating, Announces Price Target of $23
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 16, 2025 by benzinga